1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Suping ZHANG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation Blinatumomab - Acute B-cell Lymphoblastic Leukemia | Phase 4 | Recruiting | Suping ZHANG | 60 | 2023-09-01 | 2024-04-01 |
Recurrence (1)
blinatumomab (1)
China (1)